1. Dralle H. Can noninvasive follicular thyroid neoplasms with papillary-like nuclear features (NIFTP) metastasize? Chirurg. 2019; 90:501.
2. Chereau N, Greilsamer T, Mirallié E, Sadowski SM, Pusztaszeri M, Triponez F, et al. NIFT-P: are they indolent tumors? Results of a multi-institutional study. Surgery. 2019; 165:12–16.
Article
3. Xu B, Farhat N, Barletta JA, Hung YP, Biase D, Casadei GP, et al. Should subcentimeter non-invasive encapsulated, follicular variant of papillary thyroid carcinoma be included in the noninvasive follicular thyroid neoplasm with papillary-like nuclear features category? Endocrine. 2018; 59:143–150.
Article
4. Thompson LD. Ninety-four cases of encapsulated follicular variant of papillary thyroid carcinoma: a name change to noninvasive follicular thyroid neoplasm with papillary-like nuclear features would help prevent overtreatment. Mod Pathol. 2016; 29:698–707.
Article
5. Xu B, Tallini G, Scognamiglio T, Roman BR, Tuttle RM, Ghossein RA. Outcome of large noninvasive follicular thyroid neoplasm with papillary-like nuclear features. Thyroid. 2017; 27:512–517.
Article
6. Thompson LD, Poller DN, Kakudo K, Burchette R, Nikiforov YE, Seethala RR. An international interobserver variability reporting of the nuclear scoring criteria to diagnose noninvasive follicular thyroid neoplasm with papillary-like nuclear features: a validation study. Endocr Pathol. 2018; 29:242–249.
Article
7. Hirokawa M, Higuchi M, Suzuki A, Hayashi T, Kuma S, Miyauchi A. Noninvasive follicular thyroid neoplasm with papillary-like nuclear features: a single-institutional experience in Japan. Endocr J. 2017; 64:1149–1155.
Article